EMA validates type II variation for Keytruda with pemetrexed and chemotherapy in NSCLC April 24, 2018 No Comments
EMA grants orphan drug designation for ABO-202 gene therapy program in Batten disease April 23, 2018 No Comments
EMA validates MAA for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer April 4, 2018 No Comments
RSS